TABLE 1.
Participant demographic and baseline characteristics (main study)
| Influenza (n = 280) | RSV (n = 120) | |
|---|---|---|
| Age, mean (SD), years | 59.7 (16.9) | 63.1 (15.9) |
| 18 to ≤59 years, n (%) | 130 (46.4) | 47 (39.2) |
| 60 to ≤64 years, n (%) | 40 (14.3) | 12 (10.0) |
| 65 to ≤74 years, n (%) | 60 (21.4) | 34 (28.3) |
| ≥75 years, n (%) | 50 (17.9) | 27 (22.5) |
| Female, n (%) | 149 (53.2) | 81 (67.5) |
| Acute respiratory symptom length before hospitalization, mean (SD), days | 4.2 (4.1) | 5.5 (4.8) |
| ≤3 days, n (%) | 160 (57.1) | 50 (41.7) |
| >3 days, n (%) | 120 (42.9) | 70 (58.3) |
| Additional concurrent medical conditions during hospitalization, a n (%) | n = 164 | n = 75 |
| Acute exacerbation of asthma or COPD | 40 (24.4) | 25 (33.3) |
| Any transplantation | 1 (0.6) | 1 (1.3) |
| Exacerbation of congestive heart failure | 27 (16.5) | 17 (22.7) |
| Hypoxemia | 41 (25.0) | 26 (34.7) |
| Malignancy or need for diagnostic workup | 4 (2.4) | 4 (5.3) |
| Sepsis | 35 (21.3) | 11 (14.7) |
| O2 supplementation at screening visit, n (%) | 133 (47.5) | 86 (71.7) |
| NEWS scale at screening, b mean (SD) | 3.4 (2.5) | 4.3 (2.6) |
| Total clinical symptom score, mean (SD) c | 14.9 (5.4) | 16.1 (5.6) |
| 18 to ≤59 years d | 14.8 (5.4) | 15.1 (6.1) |
| 60 to ≤64 years e | 16.2 (4.5) | 19.2 (4.5) |
| 65 to ≤74 years f | 14.3 (5.8) | 16.7 (5.5) |
| ≥75 years g | 14.5 (5.4) | 15.5 (5.1) |
| Residence pre‐hospitalization, n (%) | ||
| LTCF | 2 (0.7) | 4 (3.3) |
| Private residence | 256 (91.4) | 110 (91.7) |
| Retirement community | 5 (1.8) | 2 (1.7) |
| Other | 11 (3.9) | 2 (1.7) |
| Not reported | 6 (2.1) | 2 (1.7) |
Abbreviations: COPD, chronic obstructive pulmonary disease; LTCF, long‐term care facility; NEWS, National Early Warning Score; RSV, respiratory syncytial virus; SD, standard deviation.
Additional concurrent medical conditions during hospitalization are not inclusive of one another. Responses with multiple conditions were allowed.
Data available for 271/280 patients with influenza and 109/120 patients with RSV.
Data available for 273/278 patients with influenza and 119/120 patients with RSV.
Data available for 130/130 patients with influenza and 47/47 patients with RSV.
Data available for 39/40 patients with influenza and 12/12 patients with RSV.
Data available for 57/60 patients with influenza and 34/34 patients with RSV.
Data available for 47/50 patients with influenza and 26/27 patients with RSV.